Trial intelligence / Profile preview

Nebulized vs Intravenous Tranexamic Acid for Hemoptysis

NCT07641946Phase 3Not yet recruiting

Sponsor
Assiut University
Start
Jul 2026
Primary completion
Jul 2027
01

Overview

A Phase 3 trial of tranexamic acid in hemoptysis, pulmonary hemorrhage, sponsored by Assiut University. Planned start Jul 2026; status: not yet recruiting.

02

Drugs

tranexamic acid
03

Conditions

hemoptysispulmonary hemorrhage

Beyond the preview

Go deeper on NCT07641946.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07641946.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call